During the past decade, Austin Clinical Research, LLC conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 3 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 3 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Austin Clinical Research, LLC" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Genentech, Inc." with 4 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Ionis Pharmaceuticals, Inc." with 1 trials sponsored and "Kodiak Sciences Inc" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Austin Clinical Research, LLC" #1 collaborator was "AbbVie" with 1 trials as a collaborator and "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Austin Clinical Research, LLC" are "Diabetic Macular Edema" (5 trials), "Geographic Atrophy" (4 trials), "Wet Macular Degeneration" (3 trials), "Diabetic Retinopathy" (2 trials) and "Macular Degeneration, Age-Related" (2 trials). Many other conditions were trialed in "Austin Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Austin Clinical Research, LLC" are "Drug" (20 trials), "Other" (6 trials), "Procedure" (3 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (7 trials), "Faricimab" (6 trials), "Aflibercept" (4 trials), "Placebo" (3 trials) and "Galegenimab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Austin Clinical Research, LLC" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Austin Clinical Research, LLC". undefined are not yet recruiting, 7 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Austin Clinical Research, LLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Austin Clinical Research, LLC, 3 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".